Skip to content
alcaftadine

Structure via PubChem · Public domain (PubChem)

EntityQ4712900· pop 11· linked from 3 articles

alcaftadine

Sign in to save

Also known as Lastacaft®, R-89674, Alcaftadina, 6,11-Dihydro-11-(1-Methyl-4-piperidinylidene)-5H-iMidazo[2,1-b][3]benzazepine-3-carboxaldehyde, Vilasta, Alcaftadinum

Alcaftadine, sold under the brand name Lastacaft, is an antihistamine used to help prevent itching of the eyes. It is an H1 histamine receptor antagonist. It is given as an drops in the eye.

Key facts

Drug.Verifiedfields
changed
Drug.Watchedfields
changed
Drug.verifiedrevid
477316420
Drug.image
Alcaftadine.svg
Drug.image_class
skin-invert-image
Drug.tradename
Lastacaft
Drug.MedlinePlus
a611022
Drug.DailyMedID
Alcaftadine
Drug.routes_of_administration
Eye drops
Drug.ATC_prefix
S01
Drug.ATC_suffix
GX11
Drug.legal_US
OTC
Drug.elimination_half life
~2 hrs
Drug.CAS_number
147084-10-4
Drug.PubChem
19371515
Drug.IUPHAR_ligand
7587
Drug.DrugBank
DB06766
Drug.ChemSpiderID
14201635

via Wikipedia infobox

Chemical data

Formula
C19H21N3O
Molecular weight
307.4 g/mol
IUPAC name
11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2010
Admin. routes
topical
Indications
eye allergy, allergic conjunctivitis

via ChEMBL · EBI

Wikidata facts

Mass
307.168
Has use
medication
Show 5 more facts
chemical formula
C₁₉H₂₁N₃O
canonical SMILES
CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1
World Health Organisation international non-proprietary name
alcaftadine
subject has role
H1 antagonist
Commons category
Alcaftadine
Sources (2)

via Wikidata · CC0

~2 min read

Encyclopedic overview

9 sections
Contents
  • Medical uses
  • Pharmacology
  • Adverse effects
  • Pharmacokinetics
  • History
  • Society and culture
  • Economics
  • Legal status
  • References

Alcaftadine, sold under the brand name Lastacaft, is an antihistamine used to help prevent itching of the eyes. It is an H1 histamine receptor antagonist. It is given as an drops in the eye.

It was approved for medical use in the United States in July 2010. It is available as a generic medication and as an over-the-counter medication.

Excerpted from Wikipedia’s “alcaftadine” article, available under the CC BY-SA 4.0 licence.